Home - Products - Others - Other Targets - Biotin-Kinase Domain of Insulin Receptor (5)

Biotin-Kinase Domain of Insulin Receptor (5)

CAS No. ———

Biotin-Kinase Domain of Insulin Receptor (5)( ——— )

Catalog No. M41567 CAS No. ———

Biotin-Kinase Domain of Insulin Receptor (5)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Biotin-Kinase Domain of Insulin Receptor (5)
  • Note
    Research use only, not for human use.
  • Brief Description
    Biotin-Kinase Domain of Insulin Receptor (5)
  • Description
    Biotin-Kinase Domain of Insulin Receptor (5)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    2089.07
  • Molecular Formula
    C82H124N21O35S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PTD-p65-P1 Peptide

    PTD-p65-P1 Peptide is a nuclear transcription factor NF-kappaB inhibitor, composed of a membrane-translocating peptide sequence generated from antennapedia (PTD) conjugated with p65-P1, which selectively inhibits activation induced by various inflammatory stimuli. PTD-p65-P1 suppressed NF-kappaB activation induced by lipopolysaccharide, interleukin-1, okadaic acid, phorbol 12-myristate 13-acetate, H(2)O(2), and cigarette smoke condensate as well as that induced by TNF.

  • 6-Acryloyloxyhexyl p...

    6-Acryloyloxyhexyl phosphater (PA21) is a novel phosphate-binding agent, which is an iron-based reagent, and can be used for the treatment of hyperphosphatemia in chronic kidney disease.

  • N-Benzylstearamide

    N-Benzyloctadecanamide is a distinct class of secondary metabolites in Lepidium meyenii Walp. (Maca).